Scientists at the Wake Forest Institute for Regenerative Medicine, led by its director Anthony Atala, MD, were the first in world to engineer laboratory-grown organs that were successfully implanted in humans. Today, this interdisciplinary team is working to engineer replacement tissues and organs and healing cell therapies for more than 30 different areas of the body.
Anthony Atala, MD, director of the Wake Forest Institute for Regenerative Medicine
The institute’s research-core structure promotes collaboration with industry through ready access to specialized expertise, services and equipment. More than 350 personnel—representing fields such as biomedical and chemical engineering, cell and molecular biology, biochemistry, physiology, materials science, nanotechnology, genomics, proteomics, surgery and medicine—work collaboratively in interdisciplinary, cross-functional teams to speed the process of discovery.
The institute’s internal preclinical and clinical development programs promote translation. Regenerative medicine researchers have access to a current good tissue practices and good manufacturing practices facility—the Regenerative Medicine Clinical Center—that allows for the preparation of tissues and cell therapies under U.S. Food and Drug Administration guidelines to accelerate translation and commercialization.
Broad-Based Expertise in Regenerative Medicine
The institute is internationally recognized for the broad scope of its research and expertise. Its scientists are leaders in multiple facets of regenerative medicine, including:
- Cell Therapy
- Diagnostics and Biomarkers
- Drug Discovery
- Gene Therapy
- Manufacturing and Analytic Services
- Stem Cell Biology
- Tissue Engineering
- Validation and Bioassay Development